Fresenius in talks to acquire US-based Akorn

13 April 2017 - Deborah Wilkes

Archived

German healthcare company Fresenius is in talks to acquire US generics, OTC and animal health company Akorn.

Click tags below for more information on topics:

Akorn

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: